What are the best ways to prevent and reduce adverse events of immune checkpoint inhibitors in patients with classical Hodgkin lymphoma?

Amy Goodrich, CRNP, on managing treatment-related events in classical Hodgkin lymphoma.

Learn more on this topic: Evolving Strategies to Manage Treatment-Related Adverse Events for Patients with Classical Hodgkin Lymphoma

Related Material

What is the best way to counsel patients with classical Hodgkin lymphoma on the early detection and prevention of adverse events?

What do I need to know about preventing and reducing the side effects of agents used in patients with classical Hodgkin lymphoma?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.